|
Early Combination Antiretroviral Treatment of HIV Infection Adds Decades of Life
Vendredi 25 Juillet 2008 - 07:44 - 5 mois, 2 semaines depuis - Presse spécialisée - Medscape HIV AIDS People who become infected with HIV in their 20s and 30s can expect to live into their 60s or 70s if they initiate treatment early with combination antiretroviral therapy (cART), according to an article in the July 26 issue of The Lancet by the multinational Antiretroviral Therapy Cohort Collaboration. Reuters Health Information |
|
Effective HIV Suppression Does Not Eliminate Transmission Risk
Jeudi 24 Juillet 2008 - 19:47 - 5 mois, 2 semaines depuis - Presse spécialisée - Medscape HIV AIDS Antiretroviral therapy that reduces plasma viral load to undetectable levels is no guarantee that the HIV-infected individual is no longer infectious, epidemiologists in Australia report in the July 26 issue of The Lancet. They present data suggesting that failure to use condoms following effective treatment could substantially increase sexual transmission of HIV. Reuters Health Information |
|
Malignancies in Women With HIV Infection
Jeudi 24 Juillet 2008 - 11:46 - 5 mois, 2 semaines depuis - Presse spécialisée - Medscape HIV AIDS HIV-infected women are at increased risk for certain malignancies and premalignant HPV-related changes. Screening recommendations and treatment of HIV-related cancers in women are reviewed. Women's Health |
|
Outcomes of Multidrug-resistant Patients Switched From Enfuvirtide to Raltegravir Within a Virologically Suppressive Regimen
Jeudi 24 Juillet 2008 - 07:21 - 5 mois, 2 semaines depuis - Presse spécialisée - Medscape HIV AIDS Thirty-five adults electively replaced enfuvirtide with raltegravir while the rest of their regimen was unchanged. Did they maintain virologic suppression? AIDS |
|
High-Dose Immunochemotherapy Safe for HIV-Infected Adults With Burkitt Lymphoma
Jeudi 24 Juillet 2008 - 07:03 - 5 mois, 2 semaines depuis - Presse spécialisée - Medscape HIV AIDS High-dose immunochemotherapy can safely be administered to HIV-infected patients with adult Burkitt lymphoma, according to a report in the July 1st Cancer. Reuters Health Information |
|
HIV-1 Integrase Inhibitor Effective for Resistant HIV-1
Jeudi 24 Juillet 2008 - 06:58 - 5 mois, 2 semaines depuis - Presse spécialisée - Medscape HIV AIDS In combination with an optimized background regimen, the HIV-1 integrase inhibitor raltegravir (Isentress) is an effective treatment for HIV infection with triple-class drug resistance, new research shows. Reuters Health Information |
|
Induction-maintenance Therapy for HIV-1 Infection
Mercredi 09 Juillet 2008 - 13:29 - 6 mois depuis - Presse spécialisée - Medscape HIV AIDS The superiority of combination drug therapies, highly active antiretroviral treatment over mono- and dual-therapies has created an interest in IM therapy strategies for HIV-1 infection. Future HIV Therapy |
|
NY Course 2008: Recent Additions to ART Classes
Mercredi 09 Juillet 2008 - 09:00 - 6 mois depuis - Presse spécialisée - Medscape HIV AIDS At the NY Course, Drs. DeJesus, Gulick, and Markowitz discuss the recent additions to ART classes. Medscape HIV/AIDS |
|
Immune Activation and AIDS Pathogenesis
Mardi 08 Juillet 2008 - 23:34 - 6 mois depuis - Presse spécialisée - Medscape HIV AIDS What causes immune activation in HIV infection? AIDS |
|
Frequency of HIV-Related Medication Errors and Associated Risk Factors in Hospitalized Patients
Mardi 08 Juillet 2008 - 13:04 - 6 mois depuis - Presse spécialisée - Medscape HIV AIDS An alarmingly high number of errors occur when patients with HIV infection are initially hospitalized, requiring interventions to reduce the risk of patient harm. The Annals of Pharmacotherapy |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 >
Actus fournies par : Medscape HIV/AIDS Headlines